Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases

Read more

New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry

A brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy

Read more

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus

Read more

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Read more